Hepion Pharmaceuticals, Inc. (HEPA): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$14.3K
Year ended 2023-12-31
-45.4%
3-year compound annual growth
$130.4K2014-06-30: $15.8K2015-06-30: $83.3K2016-06-30: $6.6K2017-06-30: $14.7K2019-12-31: $51.5K2020-12-31: $88.0K2021-12-31: $130.4K2022-12-31: $16.3K2023-12-31: $14.3K$14.3K
2014-06-30 Capital Expenditures (USD) 2023-12-31
Period endedCapital ExpendituresChange YoYSource filing
2023-12-31$14.3K-12.4%2025-04-08, From 2023-01-01
2022-12-31$16.3K-87.5%2024-04-16, From 2022-01-01
2021-12-31$130.4K+48.2%2023-04-10, From 2021-01-01
2020-12-31$88.0K+70.9%2022-04-08, From 2020-01-01
2019-12-31$51.5Kn/a2021-03-31, From 2019-01-01
No annual figure between 2017-06-30 and 2019-12-31.
2017-06-30$14.7K+122.8%2019-03-14, From 2016-07-01
2016-06-30$6.6K-92.1%2017-09-28, From 2015-07-01
2015-06-30$83.3K+425.5%2016-09-28, From 2014-07-01
2014-06-30$15.8Kn/a2015-09-25, From 2013-07-01